Search Results - "Pasinetti, G"

Refine Results
  1. 1

    Identification of potential CSF biomarkers in ALS by PASINETTI, G. M, UNGAR, L. H, MARCUS, S, HO, L, LANGEE, D. J, YEMUL, S, DENG, H, YUAN, X, BROWN, R. H, CUDKOWICZ, M. E, NEWHALL, K, PESKIND, E

    Published in Neurology (25-04-2006)
    “…The clinical diagnosis of ALS is based entirely on clinical features. Identification of biomarkers for ALS would be important for diagnosis and might also…”
    Get full text
    Journal Article
  2. 2

    Randomized pilot study of nimesulide treatment in Alzheimer's disease by AISEN, P. S, SCHMEIDLER, J, PASINETTI, G. M

    Published in Neurology (09-04-2002)
    “…Nonsteroidal anti-inflammatory drugs (NSAID) may be useful in the treatment of AD. Clinical and laboratory experience with nimesulide, an NSAID with…”
    Get full text
    Journal Article
  3. 3

    The Palaeobiology of Two Crown Group Cnidarians: Haootia quadriformis and Mamsetia manunis gen. et sp. nov. from the Ediacaran of Newfoundland, Canada by McIlroy, D, Pasinetti, G, Pérez-Pinedo, D, McKean, C, Dufour, S C, Matthews, J J, Menon, L R, Nicholls, R, Taylor, R S

    Published in Life (Basel, Switzerland) (30-08-2024)
    “…The Ediacaran of eastern Newfoundland preserves the world's oldest known eumetazoan body fossils, as well as the earliest known record of fossilized muscular…”
    Get full text
    Journal Article
  4. 4

    Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain by Pasinetti, G.M, Aisen, P.S

    Published in Neuroscience (01-11-1998)
    “…Many epidemiological studies suggest that use of non-steroidal anti-inflammatory drugs delays or slows the clinical expression of Alzheimer's disease, [13]but…”
    Get full text
    Journal Article
  5. 5

    Granins as disease-biomarkers: translational potential for psychiatric and neurological disorders by Bartolomucci, A, Pasinetti, G.M, Salton, S.R.J

    Published in Neuroscience (29-09-2010)
    “…Abstract The identification of biomarkers represents a fundamental medical advance that can lead to an improved understanding of disease pathogenesis, and…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    A therapeutic role for cyclooxygenase‐2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis by Pompl, P. N., Ho, L., Bianchi, M., McManus, T., Qin, W., Pasinetti, G. M.

    Published in The FASEB journal (01-04-2003)
    “…ABSTRACT Recent studies indicate that the proinflammatory enzyme cyclooxygenase (COX)‐2, an enzyme involved in inflammatory cascades but also normal neuronal…”
    Get full text
    Journal Article
  9. 9

    Potentiation of Excitotoxicity in Transgenic Mice Overexpressing Neuronal Cyclooxygenase-2 by Kelley, Kevin A., Ho, Lap, Winger, David, Freire-Moar, Jose, Borelli, Cy Blanco, Aisen, Paul S., Pasinetti, Giulio Maria

    Published in The American journal of pathology (01-09-1999)
    “…In this study we describe the generation of a transgenic mouse model with neuronal overexpression of the human cyclooxygenase-2, h(COX)-2, to explore its role…”
    Get full text
    Journal Article
  10. 10

    Cyclooxygenase and Alzheimer's disease: implications for preventive initiatives to slow the progression of clinical dementia by Pasinetti, Giulio Maria

    Published in Archives of gerontology and geriatrics (01-08-2001)
    “…Industry and academia are devoting a tremendous amount of resources to the testing of anti-inflammatory drugs for the treatment of Alzheimer's disease (AD)…”
    Get full text
    Journal Article
  11. 11

    Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia by Pasinetti, Giulio Maria

    Published in Journal of neuroscience research (15-09-2001)
    “…Alzheimer's disease (AD) is the most common form of dementia, affecting as many as 4 million older persons and results from abnormal changes in the brain that…”
    Get full text
    Journal Article
  12. 12

    Inhibition of cyclooxygenase as potential novel therapeutic strategy in N141I presenilin-2 familial Alzheimer's disease by Qin, W, Peng, Y, Ksiezak-Reding, H, Ho, L, Stetka, B, Lovati, E, Pasinetti, G M

    Published in Molecular psychiatry (01-02-2006)
    “…The present study was designed to further explore the potential cause/effect relationship between the expression of both the N141I presenilin (PS)2 mutant…”
    Get full text
    Journal Article
  13. 13

    Maturational Regulation and Regional Induction of Cyclooxygenase-2 in Rat Brain: Implications for Alzheimer's Disease by Tocco, G., Freire-Moar, J., Schreiber, S.S., Sakhi, S.H., Aisen, P.S., Pasinetti, G.M.

    Published in Experimental neurology (01-04-1997)
    “…We explored the constitutive expression, maturational regulation, and relation to kainic-acid-induced apoptosis of cyclooxygenase (COX)-2 mRNA in rat brain. In…”
    Get full text
    Journal Article
  14. 14

    Phosphorylation of tau at THR212 and SER214 in human neuronal and glial cultures: The role of AKT by Kyoung Pyo, H, Lovati, E, Pasinetti, G.M, Ksiezak-Reding, H

    Published in Neuroscience (2004)
    “…We have reported recently that the microtubule-associated protein tau is phosphorylated in vitro by Akt, an important kinase in anti-apoptotic signaling…”
    Get full text
    Journal Article
  15. 15

    Protein Kinase C Anchoring Deficit in Postmortem Brains of Alzheimer's Disease Patients by Battaini, Fiorenzo, Pascale, Alessia, Lucchi, Laura, Pasinetti, Giulio M., Govoni, Stefano

    Published in Experimental neurology (01-10-1999)
    “…Protein kinase C (PKC) has been implicated in the pathophysiology of Alzheimer's disease (AD). The levels of particular isoforms and the activation of PKC are…”
    Get full text
    Journal Article Conference Proceeding
  16. 16
  17. 17

    Complement anaphylatoxin C5a neuroprotects through mitogen‐activated protein kinase‐dependent inhibition of caspase 3 by Mukherjee, Piali, Pasinetti, Giulio Maria

    Published in Journal of neurochemistry (01-04-2001)
    “…We previously reported that pretreatment of murine cortico‐hippocampal neuronal cultures with the complement‐derived anaphylatoxin C5a, protects against…”
    Get full text
    Journal Article
  18. 18

    Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration by Osaka, H., McGinty, A., Höpken, U.E., Lu, B., Gerard, C., Pasinetti, G.M.

    Published in Neuroscience (01-02-1999)
    “…In this study we explored the potential role of the complement derived anaphylatoxin C5a and the expression of its receptor in mouse brain. Using in situ…”
    Get full text
    Journal Article
  19. 19

    Cyclooxygenase-2 Promotes Amyloid Plaque Deposition in a Mouse Model of Alzheimer's Disease Neuropathology by Xiang, Zhongmin, Ho, Lap, Yemul, Shrishailam, Zhao, Zhong, Qing, Wein, Pompl, Patrick, Kelley, Kevin, Dang, Anju, Qing, Weiping, Teplow, David, Pasinetti, Giulio Maria

    Published in Gene expression (01-01-2002)
    “…Several epidemiologic studies have reported that cyclooxygenase (COX) inhibitors prevent/delay the onset of Alzheimer's disease (AD). Recent experimental…”
    Get full text
    Journal Article
  20. 20

    Cyclooxygenase and inflammation in Alzheimer's disease: Experimental approaches and clinical interventions by Pasinetti, Giulio Maria

    Published in Journal of neuroscience research (01-10-1998)
    “…Many epidemiological studies suggest that use of non‐steroidal anti‐inflammatory drugs (NSAIDs) delay or slow the clinical expression of Alzheimer's disease…”
    Get full text
    Journal Article